| 发明名称 |
BIOMARKERS AND ASSAYS FOR THE TREATMENT OF CANCER |
| 摘要 |
<p>This invention features methods for prognosticating the efficacy of a cancer treatment comprising administration of a lymphotoxin-βreceptor (LT-β-R) using TRAF3, TRAF2, and/or p53 markers, as well as combination therapies that include a composition that activates lymphotoxin-beta receptor signaling in combination with one or more other agents.</p> |
| 申请公布号 |
EP2067041(A2) |
申请公布日期 |
2009.06.10 |
| 申请号 |
EP20070839264 |
申请日期 |
2007.10.03 |
| 申请人 |
BIOGEN IDEC MA, INC. |
发明人 |
LUKASHEV, MATVEY, E.;BISTA, PRADEEP;ZENG, WEIKE |
| 分类号 |
G01N33/574 |
主分类号 |
G01N33/574 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
